BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8212707)

  • 1. [Low dose acetylsalicylic acid in secondary prevention of stroke].
    Deecke L; Zeiler K
    Wien Klin Wochenschr; 1993; 105(17):485-7. PubMed ID: 8212707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet drugs in secondary prevention of stroke.
    Diener HC
    Int J Clin Pract; 1998 Mar; 52(2):91-7. PubMed ID: 9624789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aspirin dosage for prevention of cerebral infarct: arguments for low dosage].
    Hennerici MG; Meairs S
    Nervenarzt; 1995 Dec; 66(12):890-4; discussion 885. PubMed ID: 8584072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High dosage acetylsalicylic acid administration for prevention of acute cerebral ischemia].
    Hartmann A
    Nervenarzt; 1995 Dec; 66(12):886-9; discussion 885. PubMed ID: 8584071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Stroke Prevention Study (ESPS): results by arterial distribution.
    Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
    Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Forbes CD
    Int J Clin Pract; 1997 Jun; 51(4):205-8. PubMed ID: 9287258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin: dose and indications in modern stroke prevention.
    van Gijn J
    Neurol Clin; 1992 Feb; 10(1):193-207; discussion 208. PubMed ID: 1532629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.
    Berger JS; Brown DL; Becker RC
    Am J Med; 2008 Jan; 121(1):43-9. PubMed ID: 18187072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. UK-TIA Study Group.
    Uk-Tia Study Group
    Br Med J (Clin Res Ed); 1988 Jan; 296(6618):316-20. PubMed ID: 2894232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thromboprophylaxis for cerebrovascular disorders: acetylsalicylic acid remains the cornerstone].
    Levi M
    Ned Tijdschr Geneeskd; 2008 Feb; 152(8):423-5. PubMed ID: 18361189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis.
    Büttner T; Hellwig K; Müller T; Kuhn W
    Clin Neuropharmacol; 1998; 21(1):48-51. PubMed ID: 9579285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin to prevent heart attack and stroke: what's the right dose?
    Dalen JE
    Am J Med; 2006 Mar; 119(3):198-202. PubMed ID: 16490462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low- versus high-dose aspirin in prevention of ischemic stroke.
    Adams HP; Bendixen BH
    Clin Neuropharmacol; 1993 Dec; 16(6):485-500. PubMed ID: 9377584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of ASA and heparan sulfate in the secondary prevention of cerebrovascular disorders].
    Pennese F; Palombo V; Taormina F; Fraccalaglio L; Brillante C; Abate G
    Minerva Med; 1993 Nov; 84(11):621-6. PubMed ID: 8015690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study.
    Hennerici MG;
    Cerebrovasc Dis; 2009; 27 Suppl 3():28-32. PubMed ID: 19439938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP; Lodder J
    Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titrated initiation of acetylsalicylic acid-dipyridamole therapy reduces adverse effects and improves tolerance in patients with stroke.
    Douen AG; Medic S; Sabih M; Pageau N; Shuaib A
    J Stroke Cerebrovasc Dis; 2008; 17(6):356-9. PubMed ID: 18984426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.